Meanwhile, three independent neuroblastoma cohorts (Kocak, SEQC, TARGET) consistently revealed significantly elevated expression of NRCAM, VSTM2L, SLIT3, and ALCAM in Stage 4S tumors (Fig. 3B). This evidence concerns the gene ALCAM and neuroblastoma.